| MolName | 2-[2-[(Z)-2-(4-hydroxy-5-nitro-6-oxo-1H-pyrimidin-2-yl)ethenyl]phenoxy]-N-phenylacetamide |
| MolecularFormula | C20H16N4O6 |
| Smiles | [O-][N+](C(C(NC(/C=C\c(cccc1)c1OCC(Nc1ccccc1)=O)=N1)=O)=C1O)=O |
| InChI | InChI=1S/C20H16N4O6/c25-17(21-14-7-2-1-3-8-14)12-30-15-9-5-4-6-13(15)10-11-16-22-19(26)18(24(28)29)20(27)23-16/h1-11H,12H2,(H,21,25)(H2,22,23,26,27) |
| InChIK | OKNUCUOVJMPZDI-UHFFFAOYSA-N |
| TotalMolweight | 408.369 |
| Molweight | 408.369 |
| MonoisotopicMass | 408.106986 |
| CLogP | 0.6419 |
| CLogS | -5.31 |
| H Acceptors | 10 |
| H Donors | 3 |
| TotalSurfaceArea | 304.11 |
| Relative PSA | 0.37496 |
| PolarSurfaceArea | 145.84 |
| Druglikeness | -2.4949 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | polar activated DB |
| Shape Index | 0.6 |
| Fragments | 1 |
| Non HAtoms | 30 |
| NonCHAtoms | 10 |
| Electronegative Atoms | 10 |
| Rotatable Bond | 7 |
| Rings Closures | 3 |
| Small Rings | 3 |
| Aromatic Rings | 2 |
| Aromatic Atoms | 12 |
| Sp3Atoms | 4 |
| Symmetricatoms | 2 |
| Amides | 2 |
| BasicNitrogens | 1 |
| AcidicOxygens | 1 |
| StereoCon |
Click to Load Molecule:
1 - 2-[2-[(Z)-2-(4-hydroxy-5-nitro-6-oxo-1H-pyrimidin-2-yl)ethenyl]phenoxy]-N-phenylacetamide | 2 - 2-[2-[(Z)-2-(4-hydroxy-5-nitro-6-oxo-1H-pyrimidin-2-yl)ethenyl]phenoxy]-N-phenylacetamide